Skip to main content
Premium Trial:

Request an Annual Quote

Shimadzu USA Manufacturing Obtains ISO 13485 Certification

NEW YORK (GenomeWeb News) – Shimadzu USA Manufacturing said today it has obtained ISO 13485 certification for the manufacture of high performance liquid chromatographs and liquid chromatograph-mass spectrometry systems.

The certification allows Shimadzu USA Manufacturing to manufacture and supply analytical instruments for clinical testing in the US market, the company said, adding it will continue to register devices with the US Food and Drug Administration and support the growing demand for LC and LC-MS in the clinical testing space.

"Mass spectrometry has a growing presence in clinical research and laboratory medicine," Shinichi Matsunaga, president of Shimadzu USA Manufacturing, said in a statement. "Achieving ISO 13485 certification is a major milestone for Shimadzu and a great step towards developing mass spectrometry platforms as next-generation medical devices."

Shimadzu USA Manufacturing is the US manufacturing subsidiary of Shimadzu Corp., and is based in Canby, Ore.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.